This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Proteonic Biotechnology IP Bv, Other. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Leiden, NL (2020)
- CA Leiden, NL (2023)
Company Filing History:
Years Active: 2020-2023
Title: Pieter Victor Schut: Innovator in Gene Expression Technology
Introduction
Pieter Victor Schut is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of gene expression technology, holding 2 patents that focus on enhancing mRNA usage and translation.
Latest Patents
His latest patents revolve around the regulation of translation of expressed genes. The inventions describe mRNA usage improving and/or translation-enhancing nucleic acid sequences, along with nucleic acid constructs comprising such sequences. These innovations also include host cells that incorporate these nucleic acid constructs. Furthermore, the patents detail methods for expressing a protein of interest in a cell or organism using these nucleic acid sequences. They aim to increase the integration of such nucleic acid constructs into a genome, enhance mRNA usage and/or translation of recombinantly expressed polypeptides, and increase the number of transformants upon transformation of a cell with these constructs.
Career Highlights
Throughout his career, Pieter has worked with various companies, including Proteonic Biotechnology IP Bv. His work has significantly impacted the biotechnology sector, particularly in the area of gene expression.
Collaborations
Pieter has collaborated with notable professionals in his field, including Raymond Michael Dimphena Verhaert and Sharief Barends. These collaborations have further enriched his contributions to biotechnology.
Conclusion
Pieter Victor Schut is a distinguished inventor whose work in gene expression technology continues to influence the field. His innovative patents and collaborations highlight his commitment to advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile